DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$6.63
-0.32 (-4.60%)
Open$6.97
Previous Close$6.95
Day High$7.06
Day Low$6.61
52W High$9.56
52W Low$5.30
Volume—
Avg Volume140.6K
Market Cap231.13M
P/E Ratio—
EPS$-0.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+136.2% upside
Current
$6.63
$6.63
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 91.37M | 95.02M | 106.46M |
| Net Income | -23,881,556 | -22,351,705 | 19.04M |
| Profit Margin | -26.1% | -24.8% | 17.9% |
| EBITDA | -20,429,522 | -20,183,076 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -3.8% | -3.8% | +23.5% |
| Debt/Equity | 1.30 | 1.30 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |